{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/QLEP/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T14:35:32.847Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":7911,"canonical_name":"Quantum Leap Acquisition Corp","cik":"0002102155","uei":null,"lei":null,"duns":null,"ticker":"QLEP-UN"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":8},"count":8,"timeline":[{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Quantum Leap Acquisition Corp — 2026-08-14","url_slug":"/sec/cik-0002102155/10-q/0001213900-26-090005","accession_number":"0001213900-26-090005","importance":45},{"ts":"2026-07-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Quantum Leap Acquisition Corp — 2026-07-08","url_slug":"/sec/cik-0002102155/8-k/0001213900-26-076355","accession_number":"0001213900-26-076355","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Quantum Leap Acquisition Corp — 2026-06-29","url_slug":"/sec/cik-0002102155/8-k/0001213900-26-073229","accession_number":"0001213900-26-073229","importance":35},{"ts":"2026-06-23","kind":"sec.filing","form_type":"25-NSE","title":"25-NSE — Quantum Leap Acquisition Corp — 2026-06-23","url_slug":"/sec/cik-0002102155/25-nse/0000876661-26-000550","accession_number":"0000876661-26-000550","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Quantum Leap Acquisition Corp — 2026-06-22","url_slug":"/sec/cik-0002102155/8-k/0001213900-26-070302","accession_number":"0001213900-26-070302","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Quantum Leap Acquisition Corp — 2026-06-12","url_slug":"/sec/cik-0002102155/10-q/0001213900-26-068255","accession_number":"0001213900-26-068255","importance":45},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Quantum Leap Acquisition Corp — 2026-05-18","url_slug":"/sec/cik-0002102155/8-k/0001213900-26-058447","accession_number":"0001213900-26-058447","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"S-1/A","title":"S-1/A — Quantum Leap Acquisition Corp — 2026-04-27","url_slug":"/sec/cik-0002102155/s-1-a/0001213900-26-047663","accession_number":"0001213900-26-047663","importance":30}]}